As of Apr 20
| -0.03 / -0.50%|
The 5 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +51.52% increase from the last price of 5.94.
The current consensus among 5 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.